<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>http://debianws.lexgopc.com/wiki143/index.php?action=history&amp;feed=atom&amp;title=Nimustine</id>
	<title>Nimustine - Revision history</title>
	<link rel="self" type="application/atom+xml" href="http://debianws.lexgopc.com/wiki143/index.php?action=history&amp;feed=atom&amp;title=Nimustine"/>
	<link rel="alternate" type="text/html" href="http://debianws.lexgopc.com/wiki143/index.php?title=Nimustine&amp;action=history"/>
	<updated>2026-05-14T09:16:57Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.1</generator>
	<entry>
		<id>http://debianws.lexgopc.com/wiki143/index.php?title=Nimustine&amp;diff=6996316&amp;oldid=prev</id>
		<title>imported&gt;JWBE: removed Category:Organochlorides using HotCat</title>
		<link rel="alternate" type="text/html" href="http://debianws.lexgopc.com/wiki143/index.php?title=Nimustine&amp;diff=6996316&amp;oldid=prev"/>
		<updated>2025-04-17T08:37:52Z</updated>

		<summary type="html">&lt;p&gt;removed &lt;a href=&quot;/wiki143/index.php?title=Category:Organochlorides&quot; title=&quot;Category:Organochlorides&quot;&gt;Category:Organochlorides&lt;/a&gt; using &lt;a href=&quot;/wiki143/index.php?title=WP:HC&amp;amp;action=edit&amp;amp;redlink=1&quot; class=&quot;new&quot; title=&quot;WP:HC (page does not exist)&quot;&gt;HotCat&lt;/a&gt;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{{Short description|Chemical compound}}&lt;br /&gt;
{{Drugbox&lt;br /&gt;
| Verifiedfields = changed&lt;br /&gt;
| verifiedrevid = 444554365&lt;br /&gt;
| IUPAC_name = &amp;#039;&amp;#039;N&amp;lt;nowiki&amp;gt;&amp;#039;&amp;lt;/nowiki&amp;gt;&amp;#039;&amp;#039;-[(4-amino-2-methylpyrimidin-5-yl)methyl]-&amp;#039;&amp;#039;N&amp;#039;&amp;#039;-(2-chloroethyl)-&amp;#039;&amp;#039;N&amp;#039;&amp;#039;-nitrosourea&lt;br /&gt;
| image = Nimustine.svg&lt;br /&gt;
| alt = Structural formula of Nimustine&lt;br /&gt;
| width = 225px&lt;br /&gt;
| image2 = Nimustine 3D spacefill.png&lt;br /&gt;
| alt2 = Space-filling model of the nimustine molecule&lt;br /&gt;
| width2 = 225px&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Clinical data--&amp;gt;&lt;br /&gt;
| tradename = &lt;br /&gt;
| Drugs.com = {{drugs.com|international|nimustine}}&lt;br /&gt;
| pregnancy_AU = &amp;lt;!-- A / B1 / B2 / B3 / C / D / X --&amp;gt;&lt;br /&gt;
| pregnancy_US = &amp;lt;!-- A / B / C / D / X --&amp;gt;&lt;br /&gt;
| pregnancy_category = &lt;br /&gt;
| legal_AU = &amp;lt;!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled--&amp;gt;&lt;br /&gt;
| legal_CA = &amp;lt;!-- Schedule I, II, III, IV, V, VI, VII, VIII --&amp;gt;&lt;br /&gt;
| legal_UK = &amp;lt;!-- GSL, P, POM, CD, or Class A, B, C --&amp;gt;&lt;br /&gt;
| legal_US = &amp;lt;!-- OTC / Rx-only / Schedule I, II, III, IV, V --&amp;gt;&lt;br /&gt;
| legal_status = Rx-only&lt;br /&gt;
| routes_of_administration = [[Intravenous therapy|Intravenous]]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Pharmacokinetic data--&amp;gt;&lt;br /&gt;
| bioavailability = &lt;br /&gt;
| protein_bound = &lt;br /&gt;
| metabolism = &lt;br /&gt;
| elimination_half-life = &lt;br /&gt;
| excretion = &lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Identifiers--&amp;gt;&lt;br /&gt;
| CAS_number_Ref = {{cascite|correct|??}}&lt;br /&gt;
| CAS_number = 42471-28-3&lt;br /&gt;
| ATC_prefix = L01&lt;br /&gt;
| ATC_suffix = AD06&lt;br /&gt;
| ATC_supplemental = &lt;br /&gt;
| PubChem = 39214&lt;br /&gt;
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}&lt;br /&gt;
| DrugBank = &lt;br /&gt;
| UNII_Ref = {{fdacite|correct|FDA}}&lt;br /&gt;
| UNII = 0S726V972K&lt;br /&gt;
| KEGG_Ref = {{keggcite|correct|kegg}}&lt;br /&gt;
| KEGG = D08276&lt;br /&gt;
| ChEBI_Ref = {{ebicite|changed|EBI}}&lt;br /&gt;
| ChEBI = 75270&lt;br /&gt;
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}&lt;br /&gt;
| ChemSpiderID = 35876&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Chemical data--&amp;gt;&lt;br /&gt;
| C=9 | H=13 | Cl=1 | N=6 | O=2 &lt;br /&gt;
| SMILES = CC1=NC=C(C(=N1)N)CNC(=O)N(CCCl)N=O&lt;br /&gt;
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}&lt;br /&gt;
| StdInChI = 1S/C9H13ClN6O2/c1-6-12-4-7(8(11)14-6)5-13-9(17)16(15-18)3-2-10/h4H,2-3,5H2,1H3,(H,13,17)(H2,11,12,14)&lt;br /&gt;
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}&lt;br /&gt;
| StdInChIKey = VFEDRRNHLBGPNN-UHFFFAOYSA-N&lt;br /&gt;
}}&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Nimustine&amp;#039;&amp;#039;&amp;#039; ({{abbrlink|INN|International Nonproprietary Name}}) is a [[nitrosourea]] [[alkylating antineoplastic agent|alkylating agent]].&amp;lt;ref&amp;gt;{{Cite web|url=https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nimustine|title=NCI Drug Dictionary|website=National Cancer Institute|language=en|access-date=2019-03-17}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
It is used to treat malignant brain tumors and has proven to be rather effective.&amp;lt;ref&amp;gt;[https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:75270 CHEBI:75270 - nimustine] &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;pmid31414134&amp;quot;&amp;gt;{{cite journal | vauthors = Endo T, Inoue T, Sugiyama S, Saito R, Tominaga T | title = Regression of Recurrent Spinal Cord High-Grade Glioma After Convection-Enhanced Delivery of Nimustine Hydrochloride: Case Reports and Literature Review | journal = Operative Neurosurgery (Hagerstown, Md.) | volume = 18 | issue = 4 | pages = 451–459 | date = April 2020 | pmid = 31414134 | doi = 10.1093/ons/opz172 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist}}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{{Chemotherapeutic agents}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Alkylating antineoplastic agents]]&lt;br /&gt;
[[Category:Nitrosamines]]&lt;br /&gt;
[[Category:Nitrosoureas]]&lt;br /&gt;
[[Category:Pyrimidines]]&lt;br /&gt;
[[Category:Ureas]]&lt;br /&gt;
[[Category:Chloroethyl compounds]]&lt;br /&gt;
&lt;br /&gt;
{{Antineoplastic-drug-stub}}&lt;/div&gt;</summary>
		<author><name>imported&gt;JWBE</name></author>
	</entry>
</feed>